You may very well be right - but then again you may not.
Yours is a very narrow purely numbers-based view and are entitled to it.
But not all drugs are the same. Daybue's situation may not be limited to current performance alone. It is treating a very complex neuro condition, with much anecdotal significant success and development of strategies to overcome tolerance issues. It's value may not crystalize in the marketplace for some time to come yet. To combat that as an investment we have 2591 following hot on its heels.
I for one believe it is way too premature (and disrespectful to many affected people) to categorize it as a "dud".
How about we compare notes in a year or so. I can't wait for that year to pass in respect of Daybue and especially 2591.
- Forums
- ASX - By Stock
- NEU
- Ann: Q2 2024 update
Ann: Q2 2024 update, page-40
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.02 |
Change
0.080(0.62%) |
Mkt cap ! $1.664B |
Open | High | Low | Value | Volume |
$13.23 | $13.35 | $12.99 | $5.557M | 423.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1588 | $13.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.06 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1588 | 13.010 |
2 | 1422 | 13.000 |
2 | 3500 | 12.980 |
4 | 4561 | 12.960 |
5 | 5049 | 12.950 |
Price($) | Vol. | No. |
---|---|---|
13.060 | 1000 | 1 |
13.070 | 1709 | 2 |
13.080 | 2082 | 1 |
13.100 | 2082 | 1 |
13.120 | 2082 | 1 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online